PLUS THERAPEUTICS, INC. — All Filings
1,002 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0000950170-23-013671 | Apr 20, 2023 | Mar 31, 2023 |
| 8-K | 8-K | 0000950170-23-007414 | Mar 13, 2023 | Mar 10, 2023 |
| DEF 14A | DEF 14A | 0001193125-23-063024 | Mar 7, 2023 | Apr 20, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-016526 | Mar 6, 2023 | Mar 3, 2023 |
| 8-K | 8-K | 0001193125-23-060090 | Mar 3, 2023 | — |
| PRE 14A | PRE 14A | 0001193125-23-048931 | Feb 24, 2023 | Apr 20, 2023 |
| 8-K | 8-K | 0000950170-23-004104 | Feb 23, 2023 | — |
| 10-K | 10-K | 0000950170-23-004099 | Feb 23, 2023 | Dec 31, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010651 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010638 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010639 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010652 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010636 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010637 | Feb 17, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-010640 | Feb 17, 2023 | Feb 15, 2023 |
| SC 13G/A | — | 0000919574-23-001079 | Feb 13, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-23-001447 | Jan 4, 2023 | Dec 30, 2022 |
| 8-K | 8-K | 0001193125-22-305927 | Dec 15, 2022 | Dec 9, 2022 |
| 8-K | 8-K | 0001193125-22-293409 | Nov 28, 2022 | Nov 22, 2022 |
| 10-Q | 10-Q | 0000950170-22-019798 | Oct 20, 2022 | Sep 30, 2022 |
| 8-K | 8-K | 0000950170-22-019805 | Oct 20, 2022 | — |
| 8-K | 8-K | 0001193125-22-248711 | Sep 22, 2022 | Sep 19, 2022 |
| 8-K | 8-K | 0001193125-22-242028 | Sep 9, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-242025 | Sep 9, 2022 | — |
| 424B3 | 424B3 | 0001193125-22-223420 | Aug 18, 2022 | — |
| 8-K | FORM 8-K | 0001193125-22-223362 | Aug 17, 2022 | Aug 13, 2022 |
| EFFECT | — | 9999999995-22-002419 | Aug 17, 2022 | — |
| CORRESP | — | 0001193125-22-221204 | Aug 15, 2022 | — |
| UPLOAD | — | 0000000000-22-008659 | Aug 15, 2022 | — |
| S-1 | S-1 | 0001193125-22-215328 | Aug 9, 2022 | — |
| 8-K | 8-K | 0001193125-22-215050 | Aug 8, 2022 | Aug 2, 2022 |
| 8-K | 8-K | 0001564590-22-026158 | Jul 21, 2022 | — |
| 10-Q | 10-Q | 0001564590-22-026156 | Jul 21, 2022 | Jun 30, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-037240 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-034420 | Jun 6, 2022 | Jun 2, 2022 |
| 8-K | 8-K | 0001193125-22-162350 | May 27, 2022 | May 24, 2022 |
| 8-K | 8-K_ANNUAL_MEETING | 0001564590-22-020874 | May 20, 2022 | May 16, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-030494 | May 19, 2022 | May 17, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-025901 | Apr 28, 2022 | Apr 27, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-025719 | Apr 27, 2022 | Apr 26, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-025718 | Apr 27, 2022 | Apr 26, 2022 |
| 10-Q | 10-Q | 0001564590-22-015075 | Apr 21, 2022 | Mar 31, 2022 |
| 8-K | Q1 2022 PR 8-K | 0001564590-22-015078 | Apr 21, 2022 | — |
| DEF 14A | DEF 14A | 0001564590-22-013877 | Apr 7, 2022 | May 16, 2022 |
| DEFA14A | DEFA14A | 0001564590-22-013882 | Apr 7, 2022 | — |
| 8-K | 8-K MEDIDATA MATERIAL AGREEMENT | 0001564590-22-013497 | Apr 5, 2022 | Mar 31, 2022 |
| PRE 14A | PRE 14A | 0001564590-22-011988 | Mar 28, 2022 | — |
| 4/A | FORM 4/A SUBMISSION | 0000899243-22-012518 | Mar 28, 2022 | Nov 11, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-015201 | Mar 3, 2022 | Mar 1, 2022 |
| 8-K | 8-K | 0001564590-22-006711 | Feb 24, 2022 | — |